香港股市 已收市

Apontis Pharma AG (APPH.F)

Frankfurt - Frankfurt 延遲價格。貨幣為 EUR。
加入追蹤清單
7.14-0.06 (-0.83%)
市場開市。 截至 09:10AM CEST。

Apontis Pharma AG

Alfred-Nobel-Str. 10
Monheim am Rhein 40789
Germany
49 2173 8955 4949
https://apontis-pharma.de

版塊Healthcare
行業Drug Manufacturers—Specialty & Generic
全職員工127

高階主管

名稱標題支付行使價出生年份
Mr. Karlheinz GastChairman of the Management Board & CEO
Mr. Thomas MilzChief Product Officer & Deputy Chairman of Management Board
Mr. Thomas ZimmermannChief Financial Officer
Mr. Harald WeyandHead of Marketing
Dr. Matthias WendlHead of Sales
Ms. Susanne BöhmHead of HR
Dr. Olaf RanderathHead of Medicine
Dr. Susanne EndreßHead of QA, Drug Safety & Regulatory Affairs
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company is headquartered in Monheim am Rhein, Germany.

公司管治

截至 無 止,Apontis Pharma AG 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。